Jiuda Zhao

机构：Qinghai University, Qinghai University Affiliated Hospital · ORCID：0000-0002-1266-8943

发表论文 121 篇 · 总被引 2268 次 · h-index 23

代表论文

• Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study (2025 · EClinicalMedicine · 被引 21)
• Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial (2025 · Signal Transduction and Targeted Therapy · 被引 16)
• Risk relationship between six autoimmune diseases and malignancies: An umbrella review (2025 · Autoimmunity Reviews · 被引 8)
• Cardiovascular Events Associated with CDK4/6 Inhibitors: A Safety Meta-Analysis of Randomized Controlled Trials and a Pharmacovigilance Study of the FAERS Database (2024 · American Journal of Cardiovascular Drugs · 被引 5)
• Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 4)
• LBA25 Culmerciclib plus fulvestrant as first-line treatment for HR+/HER2- advanced breast cancer: A phase III trial (CULMINATE-2) (2025 · Annals of Oncology · 被引 4)